Alterity Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

Alterity Financial Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$826K	Sell	16,106 -124	-0.8%	-$6.51K	1.18%	25
2023 Q3	$942K	Buy	16,230 +1	+0%	+$61	1.49%	20
2023 Q2	$1.04M	Sell	16,229 -85	-0.5%	-$5.7K	1.5%	20
2023 Q1	$1.13M	Sell	16,314 -203	-1%	-$14.3K	1.66%	21
2022 Q4	$1.19M	Sell	16,517 -146	-0.9%	-$11K	1.93%	19
2022 Q3	$1.19M	Buy	16,663 +75	+0.5%	+$5.44K	1.92%	15
2022 Q2	$1.28M	Buy	+16,588	New	+$1.26M	1.9%	17
2021 Q4	$1.04M	Buy	+16,643	New	+$976K	1.11%	23
2021 Q1	$1.22M	Buy	+16,644	New	+$1.04M	1.47%	20

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Alterity Financial Group's BMY Position: Q4 2023 in Review

Alterity Financial Group reduced its Bristol-Myers Squibb (BMY) stake by 0.76% in Q4 2023, selling an estimated $6.51K and leaving 16,106 shares worth $826K. The position accounts for 1.18% of the portfolio, ranked #25.

Alterity Financial Group first reported a position in BMY in Q1 2021 and has held it in 9 quarters since. The position peaked at $1.28M in Q2 2022. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

Alterity Financial Group held 16,106 shares of Bristol-Myers Squibb worth $826K as of Q4 2023.
Alterity Financial Group sold 124 Bristol-Myers Squibb shares in Q4 2023, an estimated $6.51K.
Bristol-Myers Squibb made up 1.18% of Alterity Financial Group's portfolio in Q4 2023, its #25 holding.
Alterity Financial Group first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 9 quarters since.
Alterity Financial Group's Bristol-Myers Squibb position peaked at $1.28M in Q2 2022.
2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Alterity Financial Group's 13F filing for Q4 2023, filed 18 Jan 2024.